Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 07, 2022

Neratinib for Advanced HER2-Positive Breast Cancer

Breast Cancer Research and Treatment

 

Additional Info

Breast Cancer Research and Treatment
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital
Breast Cancer Res Treat 2022 Aug 17;[EPub Ahead of Print], N Cunningham, S Shepherd, K Mohammed, KA Lee, M Allen, S Johnston, E Kipps, S McGrath, J Noble, M Parton, A Ring, NC Turner, AFC Okines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading